StockData
Cognition Therapeutics Inc logo

Cognition Therapeutics Inc (CGTX) stock

CGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.60−0.03 (-4.75%)

Close on Nov 18, 2026Market cap $57.06MP/E –Yield –

Cognition Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Cognition Therapeutics's market cap was $64.38M on Nov 11, 2026, against $153.59M a year earlier. Over the last 5 years it ranged from $2.71M to $157.86M, with a median of $56.27M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$64.38M-46.0%
2025Dec 31, 2025$119.16M+316.4%
2024Dec 31, 2024$28.62M-49.1%
2023Dec 29, 2023$56.27M+11.8%
2022Dec 30, 2022$50.34M+1193.1%
2021Dec 31, 2021$3.89M–

More Cognition Therapeutics figures

See a number that looks wrong?